SCHEMBL17876359

SCHEMBL17876359

Cc1cc2occ(I)c(=O)c2c(C)c1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH2 P05091 1/20 0.39
ALDH1A1 P00352 4/20 0.37
POLB P06746 2/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ADORA3 P0DMS8 1/20 0.36
PTPN1 P18031 1/20 0.33
THRB P10828 1/20 0.33
ALOX15 P16050 2/20 0.33
MAOB P27338 1/20 0.32
HPGD P15428 2/20 0.31
HSD17B10 Q99714 2/20 0.31
NPC1 O15118 1/20 0.31
HCRTR1 O43613 1/20 0.31
LMNA P02545 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
TSHR P16473 1/20 0.31
KDM4E B2RXH2 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876385 0.82 KMT2A (0.33) ALDH2ALDH1A1POLBKMT2ATDP1
SCHEMBL26035377 0.81 ALOX15 (0.34) ALDH2ALDH1A1POLBKMT2ATDP1
SCHEMBL17522055 0.79 KMT2A (0.59) ALDH1A1POLBKMT2ATDP1THRB
SCHEMBL17876373 0.74 PTPN1 (0.45) ALDH1A1POLBKMT2ATDP1PTPN1
SCHEMBL26035386 0.71 MAOB (0.31) ALOX15MAOBMAPT
SCHEMBL17876367 0.69 ALDH1A1 (0.43) ALDH2ALDH1A1POLBKMT2ATDP1
SCHEMBL28914825 0.69 PTPN1 (0.63) ALDH1A1POLBKMT2APTPN1ALOX15
SCHEMBL30988475 0.68 MAPT (0.59) ALDH1A1POLBKMT2ATDP1PTPN1
SCHEMBL29266580 0.68 MAPT (0.59) ALDH1A1POLBKMT2ATDP1PTPN1
SCHEMBL17525029 0.65 ALDH2 (0.59) ALDH2ALDH1A1KMT2AADORA3THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160185745-A1 ANALOGS OF VINAXANTHONE AND XANTHOFULVIN, METHODS OF SYNTHESIS, AND METHODS OF TREATMENTS THEREOF BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160185745-A1 ANALOGS OF VINAXANTHONE AND XANTHOFULVIN, METHODS OF SYNTHESIS, AND METHODS OF TREATMENTS THEREOF VAT1, NQO1, VARS1 ALDH2 1790/4885ALDH1A1 2380/4885POLB 1216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.